Sergey L Kuznetsov

Sergey L Kuznetsov

Auto-generated profile, based on publicly available information

Sergey L Kuznetsov

National Research Centre "Kurchatov Institute

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2022 in Nanomedicine
Verified
Journal Article
Closed access
MSMaria Sokol
Maria Sokol
Nikita G YabbarovNikita G Yabbarov
Nikita G Yabbarov
MMMariia Romanovna Mollaeva
Mariia Romanovna Mollaeva
MCMargarita Chirkina
Margarita Chirkina
MMMurad Mollaev
Murad Mollaev
Elena Dmitrievna NikolskayaElena Dmitrievna Nikolskaya
Elena Dmitrievna Nikolskaya
Background: Serious side effects caused by paclitaxel formulation, containing toxic solubilizer Cremophor® EL, and its nonspecific accumulation greatly limit clinical paclitaxel application. Aim: T... Graphical abstract

1 March 2017 in Biomeditsinskaya Khimiya
Verified
Journal Article
Open access
AZA.S. Zhirnik
A.S. Zhirnik
YSY.P. Semochkina
Y.P. Semochkina
EME.Yu. Moskaleva
E.Yu. Moskaleva
NKN.I. Krylov
N.I. Krylov
ITI.A. Tubasheva
I.A. Tubasheva
EVE.A. Vorontsov
E.A. Vorontsov
Using poly(lactic-co-glycolic) acid we developed a polymeric form of niclosamide (PFN) and investigated molecular mechanisms underlying its antitumor activity against human colorectal cancer cell lines (SW837, Caco-2, COLO 320 HSR). PFN was shown to be more cytotoxic against cancer cells and less cytotoxic against normal cells (human embryonic lung fibroblasts) as compared to niclosamide. Both niclosamide and its polymeric form caused mitochondrial damage (evaluated as a decrease in rhodamine 123 accumulation) and increased the levels of reactive oxygen species, particularly mitochondrial superoxide, resulting in the oxidative damage to biomolecules. Furthermore, niclosamide and PFN induced G0/G1 cell cycle arrest.

18 June 2020 in Russian Journal of Biotherapy
Verified
Journal Article
Open access
PDF file
AKA. A. Krasheninnikova
A. A. Krasheninnikova
VZV. V. Zavarzina
V. V. Zavarzina
DPD. S. Panova
D. S. Panova
NGN. V. Gukasova
N. V. Gukasova
SKS. L. Kuznetsov
S. L. Kuznetsov
ЮПЮ. И. Полтавец
Ю. И. Полтавец
Introduction One of the perspective approaches to the development of anticancer chemotherapy drugs is the use of submicron vectorizeddelivery systems that increase the selectivity of action and reduce the toxic side effects of chemotherapy. A delivery system of docetaxel(DOC) loaded poly(lactide-co-glycolide) (PLGA) particles modified with folic acid dodecylamide (FAD) was developed (PLGA-DOC-FAD). The aim of the research was a comparative toxicological study of DOC-loaded particles and standard docetaxel solution form in acuteand subchronic experiments in mice after intravenous administration. Materials and methods The research was conducted in female C57BL/6 mice. During the study of acute toxicity, drugs were administeredin the following dose range: 20, 60, 90, 120, 160 mg/kg. Over 30 days, mortality and body weight were evaluated, pathomorphologicalstudies were performed. The study of toxicity in conditions of subchronic administration of medicine was conducted using three timesdaily administration in single doses of 11 and 22 mg/kg. Subchronic toxicity of the drugs was studied with three times daily administrationin single doses of 11 and 22 mg/kg. The necessary studies were performed within 30 days. Results With a single injection of PLGA-DOC-FAD in doses of 20, 60, 90 mg/kg, the death of animals wasn’t observed; at doses of 120 and160 mg/kg, the death of animals was detected in 1–4 days. In the case of administration of the DOC substance, the death of animalsoccurred within a day after the administration of doses of 60, 90, 120, 160 mg/kg. The pattern of intoxication was similar in case of compared drugs and manifested in hypodynamia, impaired movement coordination, hind limbs paresis, though the manifestation degreethereof was more expressed in the groups with the introduction of DOC than in the case of the introduction of PLGA-DOC-FAD. It wasdetected that the LD50 for PLGA-DOC-FAD is 140 mg/kg, and for the DOC substance – 112 mg/kg. In case of subchronic administration, the detected toxic properties of drug depend on the size of the dose applied. The administration of a single dose of 22 mg/kg of PLGA-DOC-FAD caused lethal effects (2/10), reversible delay in weight gain and leucopenia in surviving animals, and an increase in the relativemass of the spleen. The use of PLGA-DOC-FAD in a single dose of 11 mg/kg didn’t cause death, was well tolerated and characterizedby similar toxicity with the docetaxel substance. Conclusion Based on experimental data, the toxic dose levels of PLGA-DOC-FAD were determined under acute and subchronic administration. The results obtained allowed us to recommend PLGA-DOC-FAD for further examination.

26 February 2020 in Drug development & registration
Verified
Journal Article
Open access
PDF file
YPYu. I. Poltavets
Yu. I. Poltavets
SAS. V. Aleshin
S. V. Aleshin
VZV. V. Zavarzina
V. V. Zavarzina
AMA. I. Murav’eVa
A. I. Murav’eVa
ASA. A. Soboleva
A. A. Soboleva
ЮПЮ. И. Полтавец
Ю. И. Полтавец
Introduction. Docetaxel is widely used for cancer treatment. Actual issue for newly developed polymer-based Docetaxel formulations is applicability of current quality requirements. The technology of polymeric forms, including gamma-sterilization, are differ from actual Docetaxel injections technology. In this study were used PLGA-based particles with Docetaxel. The main attention was directed to studying qualitative and quantitative content of related impurities in polymeric forms during long-term storage and gamma-sterilization in comparison with pharmacopoeial requirements for Docetaxel injections.Aim. Studying of possible patterns of Docetaxel-related impurities formation between intact and gamma-irradiated batches.Materials and methods. Objects of study – lyophilizates of Docetaxel polymeric forms was previously obtained by the authors. Qualitative and quantitative analysis was performed by high pressure liquid chromatography.Results and discussion. Docetaxel-related impurities was determined and evaluated in the intact and gamma-treated batches. It was cleared, that related substances in the gamma-treated batches was different in comparison with non-treated but after vary storage periods.Conclusion. Docetaxel-loaded polymeric drugs shown proper stability during long term storage. The influence of gamma-treatment to Docetaxelrelated impurities content was found. Gamma sterilization can be promising method for novel drugs, but it needs individual study in the each case.

2 March 2026 in Drug development & registration
Verified
Journal Article
Open access
PDF file
NKNataliya Kuz'mina
Nataliya Kuz'mina
SAS. V. Aleshin
S. V. Aleshin
SKS. L. Kuznetsov
S. L. Kuznetsov
ITI. A. Tubasheva
I. A. Tubasheva
VSV. G. Shuvatova
V. G. Shuvatova
Elena Dmitrievna NikolskayaElena Dmitrievna Nikolskaya
Elena Dmitrievna Nikolskaya
Introduction. As a result of the search for more active polyfluoro-containing structural analogs of the non-steroidal antiandrogen flutamide against prostate cancer, a number of compounds were obtained, among which 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-heptadecafluoro- N -(4-nitro-3-(trifluoromethyl)phenyl)nonanamide (code F-4) was of the greatest interest for further study. The necessary data for rigorous proof of the molecular structure of this compound have not previously been obtained. Identification of impurities and quantitative assessment of their content in the F-4 substance have not been conducted. To address these issues, we used nuclear magnetic resonance (NMR) spectroscopy and high-performance liquid chromatography with ultraviolet (HPLC-UV) and tandem mass-selective detection (HPLC-MS/MS). Aim. Comprehensive analysis of the structure of compound F-4 using NMR and HPLC methods, as well as identification and quantitative assessment using them of the content of impurities in samples of the substance. Materials and methods. The object of the study were laboratory samples of the substance of compound F-4, obtained by acylation of 4-nitro-3-(trifluoromethyl)aniline with perfluoropelargonic acid chloride using a known method. The following were used for the analysis: NMR spectrometer Agilent DD2 NMR System 600; liquid chromatograph Agilent 1200 equipped with diode array detector G1315B; liquid chromatograph Agilent Infinity II equipped with mass spectrometric detector with triple quadrupole G6495C (Agilent Technologies, USA). Both chromatographs used a column Luna C18(2), 250 × 4.6 mm, 5 μm (Phenomenex, USA). Results and discussion. Structural interpretation of the 1 H, 13 C, and 19 F NMR spectra of F-4 samples, taking into account the chemical shift values of the signals, their multiplicity, and 2D experimental data, clearly indicates that F-4 has the structure of 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-heptadecafluoro- N -(4-nitro-3-(trifluoromethyl)phenyl)nonanamide. The 1 H and 19 F NMR spectra of the F-4 substance samples also contained signals of two impurity compounds not related to the starting materials. HPLC-UV method was used to separate them. Using HPLC-MS/MS with electrospray ionization in the negative mode (–ESI), high-intensity m/z signals characteristic of deprotonated molecular ions were recorded for all peaks. The structure of the detected impurities was confirmed using NMR spectroscopy. The results of quantitative determination of the relative impurity content in samples of F-4 substance using 1 H and 19 F NMR methods were virtually identical; the differences between the obtained average values were not statistically significant. Conclusion. A comprehensive study using NMR and HPLC methods revealed that compound F-4 corresponds to the structure of 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-heptadecafluoro- N -(4-nitro-3-(trifluoromethyl)phenyl)nonanamide. Two related impurities were identified in samples of substance F-4, the relative content of each impurity did not exceed 1.7 %.